Clinical Outcomes of Patients With COVID19

Status Withdrawn

Clinical Trial Summary

As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04280913
Study type	Observational
Source	Guangzhou Institute of Respiratory Disease
Contact
Status	Withdrawn
Phase
Start date	February 22, 2020
Completion date	March 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05091411` - Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)	Phase 3
Completed	`NCT05107375` - Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine	Phase 3
Active, not recruiting	`NCT05128643` - Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)	Phase 3
Completed	`NCT04988217` - Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)	Phase 1/Phase 2
Completed	`NCT04579393` - Fostamatinib for Hospitalized Adults With COVID-19	Phase 2
Withdrawn	`NCT04390217` - LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia	Phase 2
Recruiting	`NCT05047783` - Masitinib in Patients With Symptomatic Mild to Moderate COVID-19	Phase 2
Completed	`NCT04646044` - A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19	Phase 1
Not yet recruiting	`NCT06392451` - LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia	N/A
Recruiting	`NCT05092568` - Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service
Completed	`NCT05364268` - Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation
Completed	`NCT06189040` - Immunogenicity After COVID-19 Vaccines in Adapted Schedules	Phase 4
Recruiting	`NCT04401436` - COVID-19 Associated Lymphopenia Pathogenesis Study in Blood
Not yet recruiting	`NCT04395742` - 1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study
Recruiting	`NCT04388631` - Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.
Completed	`NCT05501288` - Huashi Baidu Granule in the Treatment of Pediatric Patients With Mild Coronavirus Disease 2019	N/A
Active, not recruiting	`NCT05216471` - Identify Coronavirus Disease by Chest X-ray
Terminated	`NCT04672564` - Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients	Phase 3
Completed	`NCT04967781` - Autoimmunity Contributes to the Severe Progression of COVID-19
Completed	`NCT04678830` - Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19	Phase 2